Anifrolumab Benefits Seen in Second Lupus RCT Analysis
The monoclonal anifrolumab improved BICLA responses, reduced use of prednisone, and improved skin disease in patients with SLE, particularly those with high type 1 interferon gene signatures.
Related Articles
New Gel Makes Alcohol 50% Less Toxic, Curbs Organ Damage
In a mouse model study, a gel changed how the gut metabolizes alcohol, leading to less damage and lower intoxication.
Late-Night Eaters May Have Increased Risk for Colorectal Cancer
Late eating could disrupt the peripheral circadian rhythm, part of which is found in the GI tract.
Florida Allows Doctors To Perform C-Sections Outside of Hospitals
Though touted as providing more options for pregnant patients, ob.gyns. and hospitals warn about dangers.
Is Mental Illness ‘Transmissible’?
Teens whose classmates have mental illnesses are 3% more likely to later receive a psychiatric diagnosis, study finds.
Add-On to GLP-1s Yields Greater Weight Loss
Those who received bupropion/naltrexone with GLP-1 therapy lost about 5% of body weight.
Suicide in Surgeons: The Heavy Toll of a High-Stakes Career
Medical professionals are at increased suicide risk, with 6.3% of surgeons considering suicide, compared to 4.9% for the average US adult.
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Oncologists expressed serious doubts about whether the potential benefits of irinotecan liposome are worth the extra cost.
ASCO Provides Guidance on CDK4/6 Inhibitors for Early Breast Cancer
A guideline update incorporates new high-quality evidence for the adjuvant use of CDK4/6 inhibitors in early breast cancer.
Internet Use Good for Mental Well-Being?
A study including 2 million people found that connection to the internet was generally better for mental well-being.
It Would Be Nice if Olive Oil Really Did Prevent Dementia
Does olive oil prevent dementia? Let’s weigh the evidence.